Noncytotoxic drug therapy in children with unresectable desmoid tumors

Cancer

Volumn 80, Issue 2, 1997, Pages 334-340

  Lackner, Herwig ^a   Urban, Christian ^a   Kerbl, Reinhold ^a   Schwinger, Wolfgang ^a   Beham, Alfred ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Childhood; Desmoid tumor; Endocrine therapy; Fibromatosis; Tamoxifen

Indexed keywords

ANTIESTROGEN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; TAMOXIFEN; VINBLASTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CASE REPORT; DESMOID TUMOR; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, HORMONAL; DICLOFENAC; DRUG THERAPY, COMBINATION; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; INFANT; MANDIBULAR NEOPLASMS; REMISSION INDUCTION; TAMOXIFEN; THORACIC NEOPLASMS;

EID: 0030986382     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970715)80:2<334::AID-CNCR22>3.0.CO;2-U     Document Type: Article

References (30)

1. Humar A, Chou S, Carpenter B. Fibromatosis in infancy and childhood: the spectrum. J Pediatr Surg 1993;28:1446-50.
2. Faulkner L, Hajdu S, Kher U, La Quaglia M, Exelby P, Heller G, et al. Pediatric desmoid tumor: retrospective analysis of 63 cases. J Clin Oncol 1995;13:2813-8.
3. Ure BM, Holschneider AM, Gharib M, Halsband H, Hinselmann D. Fibromatosis in infancy and childhood. Clinical experience of 7 cases, their classification and prognosis. Z Kinderchir 1988;43:27-30.
4. Klein WA, Miller HH, Anderson M, DeCosse JJ. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer 1987;60:2863-8.
5. Kinzbrunner B, Ritter S, Domingo J, Rosenthal J. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 1983;52:2201-4.
6. Wilcken N, Tattersall MH. Endocrine therapy for desmoid tumors. Cancer 1991;68:1384-8.
7. Gardner EJ, Richards RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1953;5:139-47.
8. Leppert M, Dobbs M, Scrambler P, O'Connel P, Nakamura Y, Stauffer D. The gene for familial polyposis maps to the long arm of chromosome 5. Science 1987;238:1411-3.
9. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, Petrelli NJ. Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994;74:1270-4.
10. Kiel KD, Suit HD. Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer 1984;54:2051-5.
11. Raney B, Evans A, Granowetter L, Schnaufer L, Uri A, Littmann P. Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics 1987;79:394-8.
12. Weiss AJ, Lackman RD. Low-dose chemotherapy of desmoid tumors. Cancer 1989;64:1192-4.
13. Seitzer K, Kemeny N. Successful treatment of a desmoid tumor with doxorubicin. Cancer 1993;71:2242-4.
14. Lanari A. Effect of progesterone on desmoid tumors (aggressive fibromatosis). N Engl J Med 1983;24:1523.
15. Belliveau P, Graham AM. Mesenteric desmoid tumors in Gardner's syndrome treated by sulindac. Dis Colon Rectum 1984;27:53-4.
16. Sportiello DJ, Hoogerland DL. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer 1991; 67:1443-6.
17. Waddell WR, Kirsch WM. Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 1991;161:416-20.
18. Tsukada K, Church JM, Jagelman DG, Fazio VW, McGannon E, George DR, et al. Noncytotoxic drug therapy for intra-abdominal desmoid tumors in patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35:29-33.
19. Bauernhofer T, Stöger H, Schmid M, Smola M, Gürtl-Lackner B, Höfler G, et al. Sequential treatment of recurrent mesenteric desmoid tumor. Cancer 1996;77:1061-5.
20. McAdam WF, Goligher JC. The occurrence of desmoids in patients with familial polyposis coli. Br J Surg 1970;57:618-31.
21. Rock M, Pritchard D, Reiman H, Soule E, Brewster R. Extra-abdominal desmoid tumors. J Bone Joint Surg 1984; 66A:1369-74.
22. D'Angio GJ, Clatworthy HW, Evans AE, Newton WA, Tefft M. Is the risk of morbidity and rare mortality worth the cure? Cancer 1978;41:377-80.
23. Hoffmann W, Weidmann B, Hansmann E, Grundmann E, Seeber S. Remission eines rezidivierenden Desmoidfibroms unter Therapie mit Ifosfamid. Tumor Diagnostik Therapie 1987;8:126-8.
24. Kitamura A, Kanagawa T, Yamada S, Kawai T. Effective chemotherapy for abdominal desmoid tumor in a patient with Gardner's syndrome. Dis Colon Rectum 1991;34:822-6.
25. Dominguez-Malagon HR, Alfeiran-Ruiz A, Chavarria-Xicotencatl P, Duran-Hernandez MS. Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992;69:2478-83.
26. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993;72:3244-7.
27. Reitamo JJ. The desmoid syndrome: new aspects in the cause, pathogenesis, and treatment of the desmoid tumor. Am J Surg 1986;151:230-7.
28. Lipschutz A, Jadrijevic D, Girardi S, Bruzzone S, Mardones E. Antifibromatogenic potency of 9-fluoro-derivatives of progesterone. Nature 1956;178:1396-7.
29. Svanvik J, Knutsson F, Jansson R, Ekman H. Desmoid tumor in the abdominal wall after treatment with high dose estradiol for prostate cancer. Acta Chir Scand 1982;148:301-3.
30. Lim CL, Walker MJ, Mehta RR, Das Gupta TK. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 1986;22:583-5.